Literature DB >> 1424282

Detection and characterization of immunoconglutinins in patients with systemic lupus erythematosus (SLE): serial analysis in relation to disease course.

B Nilsson1, K N Ekdahl, A Sjöholm, U R Nilsson, G Sturfelt.   

Abstract

The levels of IgA, IgG and IgM immunoconglutinins (IK) were assessed in sera from 20 patients with SLE which were followed for 8-month periods. At the time of the exacerbation, IgG IKs were significantly increased to 226 +/- 90 arbitrary units (mean +/- s.e.m.) compared with both the minimum value of 75 +/- 28 in the SLE patients and with 31 +/- 2 in healthy controls (P < 0.05). There was no difference between SLE patients and controls in the levels of IgM and IgA IKs. Most of the SLE patients in this material showed maximal IgG IK levels before exacerbation, but there was no correlation between the clinical disease index and the levels of IgG IK. The specificity of IgG IKs showed a broad diversity for microtitre-fixed C3b, iC3b, C3c and C3dg. The antibodies were of IgG1, IgG3 and in two patients, IgG4 subclass. IgG IKs were correlated to the C3d/C3 ratio which suggested that the IK responses were secondary to C3 activation. In summary, unlike other conditions associated with complement activation where elevated IgM IKs are common, an increase in IgG IK levels was observed. It is possible that this diverging IK response contributes to the pathophysiology of the disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1424282      PMCID: PMC1554629          DOI: 10.1111/j.1365-2249.1992.tb07937.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita.

Authors:  P Bernard; C Prost; P Aucouturier; N Durepaire; F Denis; J M Bonnetblanc
Journal:  J Invest Dermatol       Date:  1991-08       Impact factor: 8.551

Review 2.  The role of C3 in the immune response.

Authors:  A Erdei; G Füst; J Gergely
Journal:  Immunol Today       Date:  1991-09

3.  Low avidity antibodies to double stranded DNA in systemic lupus erythematosus: a longitudinal study of their clinical significance.

Authors:  J C Nossent; V Huysen; R J Smeenk; A J Swaak
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

Review 4.  Conglutinin and immunoconglutinins.

Authors:  P J Lachmann
Journal:  Adv Immunol       Date:  1967       Impact factor: 3.543

5.  Measurement of the complement C3 breakdown product C3d by rocket immunoelectrophoresis.

Authors:  B E Bourke; I K Moss; R N Maini
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

6.  Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus.

Authors:  Y Shirakata; S Shiraishi; K Sayama; Y Miki
Journal:  J Dermatol       Date:  1990-11       Impact factor: 4.005

7.  Immunoconglutinin in various rheumatic diseases and certain diseases suspected of an autoimmune pathogenesis.

Authors:  J Bienenstock; K J Bloch
Journal:  Arthritis Rheum       Date:  1967-06

8.  Inhibitors to factor IX contain all IgG subclasses except IgG3.

Authors:  K H Orstavik
Journal:  Folia Haematol Int Mag Klin Morphol Blutforsch       Date:  1990

9.  Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders.

Authors:  E Brouwer; J W Tervaert; G Horst; M G Huitema; M van der Giessen; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

10.  A new enzyme-linked immunosorbent assay (ELISA) for measuring immunoconglutinins directed against the third component of human complement. Findings in systemic lupus erythematosus.

Authors:  C G Durand; J J Burge
Journal:  J Immunol Methods       Date:  1984-10-12       Impact factor: 2.303

View more
  6 in total

1.  IgG autoantibodies against deposited C3 inhibit macrophage-mediated apoptotic cell engulfment in systemic autoimmunity.

Authors:  Karla D Kenyon; Caroline Cole; Fran Crawford; John W Kappler; Joshua M Thurman; Donna L Bratton; Susan A Boackle; Peter M Henson
Journal:  J Immunol       Date:  2011-08-03       Impact factor: 5.422

2.  Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare.

Authors:  Daniel J Birmingham; Joshua E Bitter; Ezinne G Ndukwe; Sarah Dials; Terese R Gullo; Sara Conroy; Haikady N Nagaraja; Brad H Rovin; Lee A Hebert
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 8.237

3.  Functional Characterization of Autoantibodies against Complement Component C3 in Patients with Lupus Nephritis.

Authors:  Vasil V Vasilev; Remi Noe; Marie-Agnes Dragon-Durey; Sophie Chauvet; Valentin J Lazarov; Boriana P Deliyska; Veronique Fremeaux-Bacchi; Jordan D Dimitrov; Lubka T Roumenina
Journal:  J Biol Chem       Date:  2015-08-05       Impact factor: 5.157

Review 4.  Interpretation of Serological Complement Biomarkers in Disease.

Authors:  Kristina N Ekdahl; Barbro Persson; Camilla Mohlin; Kerstin Sandholm; Lillemor Skattum; Bo Nilsson
Journal:  Front Immunol       Date:  2018-10-24       Impact factor: 7.561

Review 5.  Autoantibodies Against C3b-Functional Consequences and Disease Relevance.

Authors:  Vasil V Vasilev; Maria Radanova; Valentin J Lazarov; Marie-Agnes Dragon-Durey; Veronique Fremeaux-Bacchi; Lubka T Roumenina
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

Review 6.  Complement diagnostics: concepts, indications, and practical guidelines.

Authors:  Bo Nilsson; Kristina Nilsson Ekdahl
Journal:  Clin Dev Immunol       Date:  2012-11-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.